Post by AGC Biologics

Name: Scaling up isn't the only path to commercialization. In this BioSpace interview, AGC Biologics' An
Uploaded: 2026-06-10T06:00:10.608Z
Channel: AGC Biologics
Description: Scaling up isn't the only path to commercialization. In this BioSpace interview, AGC Biologics' Anders Cai Holm Hansen discusses how a modular single-use scale-out approach can help developers avoid

129,132 followers

Scaling up isn't the only path to commercialization. In this BioSpace interview, AGC Biologics' Anders Cai Holm Hansen discusses how a modular single-use scale-out approach can help developers avoid costly facility transitions, maintain process consistency, and stay flexible as demand changes. Listen to the podcast hosted by Jennifer Smith-Parker for an insider's perspective on building a more agile manufacturing strategy. https://lnkd.in/e7hChP9p #BiologicsManufacturing #yourfriendlyCDMOexpert

Video Content